|
UOB Kay Hian (stock price: S$3.70) has been on a tear, with its share price nearly tripling since mid-2024. |
The UBS Take: Structural Tailwinds and Defensive Moats
In June 2026, UBS initiated coverage on UOBKH with a "Buy rating and a target price of $4.60.
|
UOB KAY HIAN |
|
|
Share price: |
Target: |
UBS’s core thesis is built on durable drivers.
They note that "recent strength in trading activity reflects not only cyclical factors but also structural drivers (equity market reforms in SG and improving capital markets activity in HK) that should sustain commission growth over the medium term".
| Higher heights |
| "We see further upside ahead, as recent strength in trading activity reflects not only cyclical factors but also structural drivers (equity market reforms in SG and improving capital markets activity in HK) that should sustain commission growth over the medium term, despite a high base in 2026E." -- UBS |
As a result, UBS forecasts a 30% year-on-year growth in commission income for 2026.
But UBS also reckons there is a looming threat from digital challengers.
"A key medium-term risk is potential market share erosion for UOBKH... given intensifying competition from fintech platforms on pricing and digital capabilities".
Furthermore, mobile app tracking indicates that UOBKH "continues to lag fintech peers, indicating relatively weaker digital user experience and platform competitiveness".
However, UBS argues that "UOBKH has so far been able to broadly defend its market share, with headline commission rates remaining relatively stable and pricing becoming more targeted through the introduction of tiered structures for more active clients".
The broker is also defending its moat through "a broader product suite and a client base skewed towards more affluent segments".
UBS notes the broker's "client base is primarily concentrated in Singapore and likely does not rely materially on mainland Chinese retail flows as a core driver of growth".
Comparing UBS' take with Macquarie's:
|
Research Firm |
Date Issued |
Target Price |
Basis |
|
Macquarie |
16 Jan 2026 |
S$3.12 |
Valuation based on 10.5x 27e P/E. This multiple was chosen because it is the "mid-point between local listed financial services players (13.1x) and +1 standard deviation on the stock's five-year trading history (7.8x)". |
|
UBS |
June 2026 |
S$4.60 |
Valuation based on a 14x forward P/E multiple. This is a premium compared to regional peers (~11x); UBS says "it is warranted given UOBKH’s superior earnings growth (c15% CAGR in 2026-27E) – almost double that of Asia peers". |
| Comparing with Macquarie’s January Perspective |
Looking back at Macquarie Equity Research’s initiation in January 2026 reveals how the narrative has evolved.
Back then, UOBKH was trading at just S$2.67.
Macquarie initiated with an "Outperform" rating and a S$3.12 price target based on a liquidity wave.
Macquarie identified UOBKH as a primary beneficiary of broader market liquidity, expecting "stock market reforms in Singapore to drive a broadening of liquidity into small and mid-caps and more retail participation over time".
Interestingly, while UBS focused on Hong Kong's recovery as a secondary driver, Macquarie placed a spotlight on Malaysia—UOBKH's third-largest market—as their "preferred market in ASEAN" and a key catalyst for upside.
From a valuation standpoint, Macquarie was more conservative early in the year, setting their target based on a 10.5x 2027 P/E multiple.
The evolution from Macquarie's January report to UBS's June analysis illustrates a market waking up to UOBKH's potential.
|
→ See also:As Market Rally Spreads, Macquarie Initiates Broker UOB-Kay Hian at Outperform
